Zhou ZP, Tan XL, Zhao ZM, Gao YX, Song YY, Jia YZ, Li CG. Robotic resection of duodenal gastrointestinal stromal tumour: Preliminary experience from a single centre. World J Gastrointest Oncol 2021; 13(7): 706-715 [PMID: 34322199 DOI: 10.4251/wjgo.v13.i7.706]
Corresponding Author of This Article
Cheng-Gang Li, MD, PhD, Associate Professor, Department of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China. lcgang301@126.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Zhi-Peng Zhou, Xiang-Long Tan, Zhi-Ming Zhao, Yuan-Xing Gao, Yu-Yao Song, Yu-Ze Jia, Cheng-Gang Li, Department of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing 100853, China
Author contributions: Zhou ZP and Tan XL contributed equally to this work, and are considered co-first authors; Zhou ZP and Tan XL analyzed and interpreted the data and wrote the article; Zhao ZM, Gao YX, Song YY and Jia YZ drafted the work and collected the data; Li CG designed the study and revised the article for important intellectual content.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Chinese PLA General Hospital (approval No. S2016-098-02).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All authors declare no conflicts of interest related to this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Cheng-Gang Li, MD, PhD, Associate Professor, Department of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China. lcgang301@126.com
Received: March 11, 2021 Peer-review started: March 11, 2021 First decision: April 19, 2021 Revised: April 19, 2021 Accepted: June 4, 2021 Article in press: June 4, 2021 Published online: July 15, 2021
ARTICLE HIGHLIGHTS
Research background
Surgical resection can achieve radical cure of duodenal gastrointestinal stromal tumors (DGISTs); however, there is no consensus on the choice of surgical technique.
Research motivation
The application of robotic surgery in the treatment of DGISTs.
Research objectives
Summarize the experience of a single center treating DGISTs by robotic resection.
Research methods
The perioperative and demographic outcomes of a consecutive series of patients who underwent robotic surgery to treat DGISTs were retrospectively analyzed.
Research results
Of the 28 patients enrolled, 11 patients underwent open surgery, and 17 patients underwent robotic surgery. All the tumours were R0 resected, and there were no significant differences in age, sex, tumour size, operation mode, postoperative hospital stay, tumour mitosis, incidence of postoperative complications, risk classification, postoperative targeted drug therapy or postoperative recurrence between the two groups (P > 0.05). Operation time and estimated blood loss in the robotic group were significantly different to those in the open surgery group (P < 0.05). No significant difference in recurrence-free survival was noted between the open surgery group and the robotic surgery group (P > 0.05).
Research conclusions
Robotic resection is safe and feasible for patients with DGISTs, and its therapeutic effect is equivalent to open surgery.
Research perspectives
Accumulation of experience in the treatment of DGISTs using robotic resection is required.
